RS51505B - Korišćenje lh u kontrolisanoj hiperstimulaciji ovarijuma - Google Patents
Korišćenje lh u kontrolisanoj hiperstimulaciji ovarijumaInfo
- Publication number
- RS51505B RS51505B YUP-212/04A YUP21204A RS51505B RS 51505 B RS51505 B RS 51505B YU P21204 A YUP21204 A YU P21204A RS 51505 B RS51505 B RS 51505B
- Authority
- RS
- Serbia
- Prior art keywords
- ovarian hyperstimulation
- controlled ovarian
- coh
- fsh
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Upotreba luteinizirajućeg hormona (LH) ili njegovog analoga, za proizvodnju medikamenta za indukciju multiple folikulofgeneze kod humanih pacijentkinja naznačeno time da se taj medikament daje tokom perioda prajminga koji počinje 1. dana stimulatorne faze kod kontrolisane ovarijalne hiperstimulacije (COH), i ne nastavlja se posle 4. dana stimulatorne faze COH, naznačeno time da se medikament LH daje u odsustvu davanja egzogenog hormonaza stimulaciju folikula (FSH) tokom perioda prajminga i naznačeno time da se davanje FSH inicira tek kada se davanje LH obustavi.Prijava sadrži još 7 patentnih zahteva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01307755 | 2001-09-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU21204A YU21204A (sh) | 2006-08-17 |
RS51505B true RS51505B (sr) | 2011-06-30 |
Family
ID=8182260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-212/04A RS51505B (sr) | 2001-09-12 | 2002-09-12 | Korišćenje lh u kontrolisanoj hiperstimulaciji ovarijuma |
Country Status (28)
Country | Link |
---|---|
US (1) | US7341989B2 (sr) |
EP (1) | EP1434600B1 (sr) |
JP (1) | JP2005504072A (sr) |
KR (1) | KR20040032953A (sr) |
CN (1) | CN1302806C (sr) |
AR (1) | AR036591A1 (sr) |
AT (1) | ATE427755T1 (sr) |
AU (1) | AU2002331939B2 (sr) |
BR (1) | BR0212502A (sr) |
CA (1) | CA2457067A1 (sr) |
CY (1) | CY1110487T1 (sr) |
DE (1) | DE60231892D1 (sr) |
DK (1) | DK1434600T3 (sr) |
EA (1) | EA009210B1 (sr) |
ES (1) | ES2322136T3 (sr) |
HK (1) | HK1067866A1 (sr) |
HR (1) | HRP20040070A2 (sr) |
IL (1) | IL160781A0 (sr) |
ME (1) | MEP38808A (sr) |
MX (1) | MXPA04002125A (sr) |
NO (1) | NO327154B1 (sr) |
PL (1) | PL205472B1 (sr) |
PT (1) | PT1434600E (sr) |
RS (1) | RS51505B (sr) |
SI (1) | SI1434600T1 (sr) |
UA (1) | UA78970C2 (sr) |
WO (1) | WO2003022301A2 (sr) |
ZA (1) | ZA200401008B (sr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ536984A (en) * | 2002-06-07 | 2008-01-31 | Ares Trading Sa | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
US20040248784A1 (en) * | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
CN102296047B (zh) * | 2011-08-13 | 2013-03-13 | 新疆农垦科学院 | 利用羔羊超排卵母细胞生产体外胚胎的方法 |
US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
US9282995B2 (en) * | 2011-12-22 | 2016-03-15 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
WO2014159813A1 (en) | 2013-03-13 | 2014-10-02 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
RU2629871C1 (ru) * | 2016-03-22 | 2017-09-04 | Сергей Михайлович Юдин | Препарат для стимуляции фолликулогенеза и способ его применения |
IT202000022015A1 (it) * | 2020-09-18 | 2022-03-18 | Marca Antonio La | Nuovo uso dell'ormone luteinizzante |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
IT1250075B (it) | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | Composizioni farmaceutiche contenenti gonadotropine. |
CN1352566A (zh) * | 1999-05-07 | 2002-06-05 | 应用研究系统Ars股份公司 | 促性腺激素 |
-
2002
- 2002-09-12 RS YUP-212/04A patent/RS51505B/sr unknown
- 2002-09-12 DE DE60231892T patent/DE60231892D1/de not_active Expired - Lifetime
- 2002-09-12 AR ARP020103455A patent/AR036591A1/es not_active Application Discontinuation
- 2002-09-12 BR BR0212502-1A patent/BR0212502A/pt not_active Application Discontinuation
- 2002-09-12 MX MXPA04002125A patent/MXPA04002125A/es active IP Right Grant
- 2002-09-12 PL PL367343A patent/PL205472B1/pl unknown
- 2002-09-12 US US10/487,423 patent/US7341989B2/en not_active Expired - Fee Related
- 2002-09-12 PT PT02767637T patent/PT1434600E/pt unknown
- 2002-09-12 WO PCT/GB2002/004147 patent/WO2003022301A2/en active Application Filing
- 2002-09-12 AU AU2002331939A patent/AU2002331939B2/en not_active Ceased
- 2002-09-12 ME MEP-388/08A patent/MEP38808A/xx unknown
- 2002-09-12 ES ES02767637T patent/ES2322136T3/es not_active Expired - Lifetime
- 2002-09-12 CN CNB028175743A patent/CN1302806C/zh not_active Expired - Fee Related
- 2002-09-12 KR KR10-2004-7002589A patent/KR20040032953A/ko not_active Application Discontinuation
- 2002-09-12 JP JP2003526429A patent/JP2005504072A/ja active Pending
- 2002-09-12 IL IL16078102A patent/IL160781A0/xx unknown
- 2002-09-12 EA EA200400428A patent/EA009210B1/ru not_active IP Right Cessation
- 2002-09-12 SI SI200230815T patent/SI1434600T1/sl unknown
- 2002-09-12 CA CA002457067A patent/CA2457067A1/en not_active Withdrawn
- 2002-09-12 AT AT02767637T patent/ATE427755T1/de active
- 2002-09-12 DK DK02767637T patent/DK1434600T3/da active
- 2002-09-12 EP EP02767637A patent/EP1434600B1/en not_active Revoked
- 2002-12-09 UA UA2004031858A patent/UA78970C2/uk unknown
-
2004
- 2004-01-23 HR HR20040070A patent/HRP20040070A2/hr not_active Application Discontinuation
- 2004-02-06 ZA ZA2004/01008A patent/ZA200401008B/en unknown
- 2004-03-08 NO NO20040990A patent/NO327154B1/no not_active IP Right Cessation
-
2005
- 2005-02-22 HK HK05101453A patent/HK1067866A1/xx not_active IP Right Cessation
-
2009
- 2009-06-30 CY CY20091100694T patent/CY1110487T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stanhope et al. | The mechanism of the adolescent growth spurt induced by low dose pulsatile GnRH treatment | |
GEP19981264B (en) | Erection-inducing methods and pharmaceutical compositions (its variants) | |
DE69105202D1 (de) | System zur verabreichung von medikamenten durch ein zweistufiges iontophoresenverfahren. | |
RS51505B (sr) | Korišćenje lh u kontrolisanoj hiperstimulaciji ovarijuma | |
ZA924772B (en) | Delayed therapy | |
ATE383168T1 (de) | Fgf-2 zur behandlung von erkrankungen der peripheralen arterien | |
DE69533112D1 (de) | Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken | |
MXPA03006217A (es) | Sistema de administracion espaciada de farmacos. | |
SE9301290D0 (sv) | Anvaendning av en somatostatinanalog | |
Fortier et al. | Functional interrelationships between the adenohypophysis, thyroid, adrenal cortex and gonads. | |
Knobil | The wisdom of the body revisited | |
YU56702A (sh) | Korišćenje fsh za lečenje neplodnosti | |
IL161665A0 (en) | Method of administering a thymosin alpha 1 peptide | |
MY106603A (en) | Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon | |
WO2003103770A3 (en) | METHOD OF CONTROLLED OVARIAN HYPERSTIMULATION AND PAHRMACEUTICAL KIT FOR THIS USE | |
Biskind | The relation of nutritional deficiency to impaired libido and potency in the male | |
EP1207902A2 (de) | VERWENDUNG VON WACHSTUMSHORMON (hGH) ZUR THERAPIE SEXUELLER FUNKTIONSSTÖRUNGEN | |
EA199800770A1 (ru) | Лекарственный препарат для терапевтического лечения вирусного гепатита | |
Wuttke | Failure to Induce Pseudopregnancy in Na—Pentobarbital—Anesthetized Rats: Effects on Serum Prolactin and LH | |
DE4110422A1 (de) | Arzneimittel enthaltend humanes corticotropin-releasing hormon (crh) und/oder dessen derivate und/oder glucocorticoide natuerlicher und/oder synthetischer provenienz | |
MX2022012353A (es) | Metodos para el inicio de la dosis de los tratamientos con aripiprazol. | |
Romano et al. | Clinical effect of human-fibroblast-derived (Beta) interferon in treatment of adeno-virus epidemic keratoconjunctivitis and its complications | |
Preboth | New drug indication for menotropins | |
UA79424C2 (en) | Use of fsh for treatment of infertility in women | |
MD1610F1 (en) | Method of the recidivating chronic aphthous stomatitis treatment |